Masaryk Memorial Cancer Institute (MMCI) in Brno is a specialized oncology center with supraregional competence with two quality certificates.

Firstly, the quality certificate of the Czech Society for Accreditation in Healthcare, Ltd.– from October 2018 - for 3 years (we were awarded previously the accreditation of the United Accreditation Commission of the Czech Republic 5 times in a row) and in May 2017 the MMCI obtained the European accreditation certificate as the Clinical Cancer Center (OECI). It confirms that the institute meets the standards of quality of oncological care and research established by the OECI (Organization of European Oncological Institutions) and is the first and so far the only one in the Czech Republic to receive this kind of accreditation.

The institute concentrates all essential branches of medicine to ensure complex oncological care, including prevention, epidemiologics, diagnostics, and particular modalities of cancer treatment and physiotherapy. Focusing on research and scientific activities including basic research, the institute is also involved in pregradual and postgradual education of doctors and other healthcare professionals as well as popular science activities aimed at wide public.

On Žlutý kopec, the newest approaches in surgery of tumors are applied in Werner building and up-to-date approach is characteristic also for the radiotherapy in Masaryk building. At present time, the newest methods in systemic therapy (cytostatics, hormonal therapy, targeted therapy) are used in the institute, which takes part in European and global clinical evaluations testing the efficacy and safety of new drugs, methods or their combinations.

In long-term, both the professionals and the patients rate the institute among the best healthcare organizations in the Czech Republic.